Transgenomic Launches EGFR CLIA Test That Accurately Detects Key Mutations in Solid and Liquid Patient Samples Using Multiplexed ICE COLD-PCR

By: via Benzinga
Transgenomic, Inc. (NASDAQ: TBIO) today announced the launch of its new Multiplexed ICE COLD-PCR™ (MX-ICP) CLIA service for mutation ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.